Item 5.02 Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers.
(b) Resignation of Executive Officer
On October 4, 2019, F.
Jody Read stepped down from his position as Chief Executive Officer of the Registrant due to increased workload in the Registrant’s
wholly-owned operating subsidiary. Mr. Read remains as a director and Chief Operating Officer of the Registrant.
(c) Appointment of Executive Officer
Concurrent with Mr. Read
stepping down from the position of Chief Executive Officer, the Registrant appointed Mr. Gary J. Grieco to act as President and
Chief Executive Officer of the Registrant.
(d) Election of New Directors
Pursuant to the September
18, 2019 majority consent of stockholders in lieu of an annual meeting (See Item 5.07 below), the Registrant elected four members
to its Board of Directors. The board of directors and their terms are as follows:
|
Name
|
|
Age
|
|
Position(s) Held
|
|
Class of Director
|
|
Director Term
|
|
Gregory W. Albers
|
|
|
70
|
|
|
Existing Director and Secretary/Treasurer
|
|
Class II
|
|
Two Years (expiring 2021)
|
|
Paul Branagan
|
|
|
76
|
|
|
Current Director
|
|
Class II
|
|
Two Years (expiring 2021)
|
|
Francis J. Read
|
|
|
54
|
|
|
Current Director; COO
|
|
Class III
|
|
One Year (expiring 2020)
|
|
William E. Prince
|
|
|
68
|
|
|
Current Director
|
|
Class III
|
|
One Year
(expiring 2020)
|
CLASS II DIRECTORS (serving two year terms expiring at the
2021 annual meeting):
Gregory W. Albers
-- Mr. Albers was appointed to fill a vacancy on our Board and to serve as Secretary/Treasurer on April 1, 2016. He is the President
and Chief Executive Officer of Life Insurance Buyers, Inc., a life insurance brokerage. Since 1995 to the present, Mr. Albers has
worked in the viatical and life settlement industry and, based on his experience, he has testified as an expert regarding that
industry’s issues in Kansas legislative committees. Prior to 1995 he worked as an independent life broker and a New England
Life Insurance Company insurance agent. He earned a Bachelor’s degree in Business from Kansas State University.
Mr. Albers experience owning
and operating his insurance business may prove helpful in management of our subsidiary’s operations. Prior to his appointment,
Mr. Albers has not had any related party transactions with the Company or its affiliates and he has no family relationship with
any current executive officer or director of the Company.
Paul Branagan
– was appointed as a director of the Company on March 23, 2018. From 1993 to the present Mr. Branagan has been the President
and Senior Scientist of Branagan & Associates, Inc. Mr. Branagan is a physicist with over 40 years of experience in a variety
of technical ventures ranging from nuclear weapons development, improving and monitoring civil structural and construction activities
to enhanced energy development for the oil and gas industry. Most of his efforts involved large scale commercialization and Research
& Development (R&D) in advanced technical projects. Mr. Branagan has authored and co-authored numerous papers, articles
and presentations covering a broad range of technical accomplishments. Many involved topical oil and gas R&D activities and
their ultimate commercialization. In addition to being a Distinguished Lecturer he has also served on a numerous symposium committees
charged with reviewing, editing and selecting the most advanced and topical technical articles for presentation. Mr. Branagan graduated
from the University of Las Vegas Nevada with a B.S. in physics.
CLASS III DIRECTORS (serving one year terms expiring at the
2020 annual meeting):
Francis J. Read
– was appointed as a director of the Company on March 23, 2018. On November 8, 2018, Mr. Read became the Chief Executive
Officer of PCT LTD. In 2017, Mr. Read became the Chief Operations Officer for Paradigm Convergence Technologies Corp., the Company’s
wholly-owned operating subsidiary. In 1998, Mr. Read founded and since 2016 has served as the CEO of CSA Service Solutions, a $44
million field support company specializing in providing support solutions for large equipment manufacturers. CSA has over 350 employees
nationwide with over 270 engineers operating in the Healthcare, Clinical Education, Life Sciences, Security, and Power Industries.
Mr. Read holds a MBA from Tulane University and a BS, electronic Engineering from DeVry Institute of Technology.
William E. Prince
– was appointed as a director of the Company on March 23, 2018. Since 2014, Mr. Prince has served as Sr. Vice President Sales
& Marketing for Paradigm Convergence Technologies Corp., the Company’s wholly-owned operating subsidiary. For two years
prior to joining Paradigm, Mr. Prince was an independent consultant in the electro-chemically activated solution industry. From
2003 through 2011, Mr. Prince was the President, CEO and Chairman of Integrated Environmental Technologies, Ltd, a publicly traded
company with its common stock registered under the 34 Act.
The Registrant’s Bylaws allow for the
appointment of up to seven directors. The Board may appoint up to two additional Class III directors to fill such vacancies at
any time prior to the next annual meeting or at any time there is a vacancy on the Board.
Item 5.03 Amendments to Articles of Incorporation or Bylaws;
Change in Fiscal Year.
Pursuant to the September 18, 2019 majority
consent of stockholders in lieu of an annual meeting (See Item 5.07 below), the Registrant amended its Articles of Incorporation
effective as of October 4, 2019.
Amended Articles of Incorporation
The Registrant amended
Article V, Section 1 of its Articles of Incorporation to increase its authorized shares of common stock from 300,000,000 to 1,000,000,000.
A copy of the amendment to the articles of incorporation are attached hereto as Exhibit 3.1.
Seris C Convertible Preferred Stock
Pursuant to the September
18, 2019 majority consent of stockholders in lieu of an annual meeting (including the consent of the Series A Convertible Preferred
Stockholders), the Registrant filed a Certificate of Designation with the Nevada Secretary of State designating 5,500,000 shares
of its authorized preferred stock as Series C Convertible Preferred Stock. The Registrant is awaiting the file stamped Certificate
of Designation from the Nevada Secretary of State. The rights and preferences of such preferred stock are as follows:
The
number of shares constituting the Series C Convertible Preferred Stock shall be 5,500,000. Such number of shares may be increased
or decreased by resolution of the Board; provided, that no decrease shall reduce the number of shares of Series C Convertible
Preferred Stock to a number less than the number of shares then outstanding plus the number of shares reserved for issuance upon
the exercise of outstanding options, rights or warrants or upon the conversion of any outstanding securities issued by the Company
convertible into Series C Convertible Preferred Stock.
|
|
1.
|
DESIGNATION. The Shares are designated as the Company’s Series C Convertible Preferred
Stock (the “Shares”).
|
|
|
2.
|
CONVERSION. The holders of the Shares shall have conversion rights as follows (the “Conversion
Rights”):
|
(a) Right
to Convert. Each Share shall be convertible into shares of the Company’s Common Stock at a price per share of $0.01 (1
Share converts into 100 shares of Common Stock) (the “Conversion Price”), at the option of the holder thereof,
at any time following the date of issuance of such Share and on or prior to the fifth (5th) day prior to a redemption
Date, if any, as may have been fixed in any redemption notice with respect to the Shares, at the office of this Company or any
transfer agent for such stock.
(b) Mechanics
of Conversion. Before any holder of Shares shall be entitled to convert the same into shares of Common Stock, he shall surrender
the certificate or certificates therefor, duly endorsed, at the office of this Company or of any transfer agent for the Shares,
and shall give written notice to this Company at its principal corporate office, of the election to convert the same and shall
state therein the name or names in which the certificate or certificates for shares of Common Stock are to be issued. This Company
shall, as soon as practicable thereafter, issue and deliver at such office to such holder of Shares, or to the nominee or nominees
of such holder, a certificate or certificates for the number of shares of Common Stock to which such holder shall be entitled as
aforesaid. Such conversion shall be deemed to have been made immediately prior to the close of business on the date of such surrender
of the shares of Shares to be converted, and the person or persons entitled to receive the shares of Common Stock issuable upon
such conversion shall be treated for all purposes as the record holder or holders of such shares of Common Stock as of such date.
(d) No
Impairment. This Company will not, by amendment of its Articles of incorporation or through any reorganization, recapitalization,
transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek
to avoid the observance or performance of any of the terms to be observed or performed hereunder by this Company, but will at all
times in good faith assist in the carrying out of all the provisions of this section and in the taking of all such action as may
be necessary or appropriate in order to protect the Conversion Rights of the holders of the Shares against impairment.
(e) Reservation
of Stock Issuable Upon Conversion. This Company shall at all times reserve and keep available out of its authorized but unissued
shares of Common Stock, solely for the purpose of effecting the conversion of the shares of the Shares, such number of its shares
of Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of the Shares; and
if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of
all then outstanding shares of the Shares, in addition to such other remedies as shall be available to the holder of such Shares,
this Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but
unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes, including, without limitation,
engaging in best efforts to obtain the requisite stockholder approval of any necessary amendment to the Company’s Certificate
of incorporation.
(f) Notice.
Any notice required by the provisions of this section to be given to the holders of Shares shall be deemed given if deposited in
the United States mail, postage prepaid, and addressed to each holder of record at his address appearing on the books of this Company.
|
|
3.
|
OTHER RIGHTS. Except as otherwise stated herein, there are no other rights, privileges,
or preferences attendant or relating to in any way the Shares, including by way of illustration but not limitation, those concerning
dividend, ranking, other conversion, other redemption, participation, or anti-dilution rights or preferences.
|
|
|
4.
|
Voting Rights. The holder of each Share shall
not have any voting rights, except in the case of voting on a change in the preferences of Shares.
|
|
|
5.
|
Protective Provisions. So long as any Shares
are outstanding, this Company shall not without first obtaining the approval (by vote or written consent, as provided by law) of
the holders of Shares which is entitled, other than solely by law, to vote with respect to the matter, and which Shares represents
at least a majority of the voting power of the then outstanding Shares:
|
(a) sell,
convey, or otherwise dispose of or encumber all or substantially all of its property or business or merge into or consolidate with
any other corporation (other than a wholly-owned subsidiary corporation) or effect any transaction or series of related transactions
in which more than fifty percent (50%) of the voting power of the Company is disposed of;
(b) alter
or change the rights, preferences or privileges of the Shares so as to affect adversely the Shares;
(c) increase
or decrease (other than by redemption or conversion) the total number of authorized shares of preferred stock;
(d) authorize
or issue, or obligate itself to issue, any other equity security, including any other security convertible into or exercisable
for any equity security (i) having a preference over, or being on a parity with, the Shares with respect to upon liquidation, or
(ii) having rights similar to any of the rights of the Preferred Stock; or
(e) amend
the Company’s Articles of Incorporation or bylaws.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On September 18, 2019,
the following consenting Voting Stockholders owning a total of 1,000,000 shares of the Registrant’s Series B Preferred stock
delivered the executed written consent authorizing the amendment to the Articles of Incorporation, election of directors and approving
the Series C Convertible Preferred Stock (collectively the “Actions”). As of September 18, 2019, the Registrant had
240,774,150 shares of Common Stock issued and outstanding and entitled to vote, which for voting purposes are entitled to one vote
per share. Each share of Series B Preferred stock is entitled to cast five hundred (500) votes for each share held of the Series
B Preferred stock on all matters presented to the stockholders of the Registrant for stockholder vote, thereby allowing such Series
B Preferred stock to cast votes totaling 500,000,000 million shares of common stock (which exceeds the number of shares of common
stock outstanding by approximately 208%). The consenting Voting Stockholders’ names, affiliation with the Company and holdings
are as follows:
|
Name
|
|
Affiliation with the Company
|
|
Number of Voting Shares
|
|
% of Total
Voting Shares
|
|
Gary J. Grieco
|
|
Chairman of the Board, President
|
|
|
250,000,000
|
|
|
|
104
|
%
|
|
Francis J. Read
|
|
Director, COO
|
|
|
250,000,000
|
|
|
|
104
|
%
|
|
Total
|
|
|
|
|
500,000,000
|
|
|
|
208
|
%
|
Pursuant to the Registrant’s
existing Bylaws and the NRS, the holders of the issued and outstanding shares of Common Stock representing a majority of our voting
power may approve and authorize the Actions by written consent as if such Actions were undertaken at a duly called and held meeting
of stockholders. In order to significantly reduce the costs and management time involved in soliciting and obtaining
proxies to approve the Actions, and in order to effectuate the Actions as early as possible, the Board elected to utilize, and
did in fact obtain, the written consent of the voting stockholders. The written consent satisfies the stockholder approval
requirement for the Actions. Accordingly, under the NRS and the Bylaws, no other approval by the Board or stockholders
of the Registrant is required in order to effect the Actions.